azacitidine

Generic: azacitidine

Labeler: armas pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name azacitidine
Generic Name azacitidine
Labeler armas pharmaceuticals inc.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS SUBCUTANEOUS
Active Ingredients

azacitidine 100 mg/1

Manufacturer
Armas Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 72485-201
Product ID 72485-201_ca345575-17a6-43a3-aa02-3d4bb9d136c5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207518
Listing Expiration 2026-12-31
Marketing Start 2018-09-10

Pharmacologic Class

Established (EPC)
nucleoside metabolic inhibitor [epc]
Mechanism of Action
nucleic acid synthesis inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72485201
Hyphenated Format 72485-201

Supplemental Identifiers

RxCUI
485246
UPC
0372485201013
UNII
M801H13NRU
NUI
N0000000233 N0000175595

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name azacitidine (source: ndc)
Generic Name azacitidine (source: ndc)
Application Number ANDA207518 (source: ndc)
Routes
INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (72485-201-01)
source: ndc

Packages (1)

Ingredients (1)

azacitidine (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "ca345575-17a6-43a3-aa02-3d4bb9d136c5", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0372485201013"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["5c0a2d5f-8c34-4c04-8425-7543965cedd4"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (72485-201-01)", "package_ndc": "72485-201-01", "marketing_start_date": "20180910"}], "brand_name": "AZACITIDINE", "product_id": "72485-201_ca345575-17a6-43a3-aa02-3d4bb9d136c5", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "72485-201", "generic_name": "azacitidine", "labeler_name": "Armas Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AZACITIDINE", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA207518", "marketing_category": "ANDA", "marketing_start_date": "20180910", "listing_expiration_date": "20261231"}